The approval process for new drugs and medical devices can be complicated and expensive. At WTW we provide the speed, efficiency and accuracy clinical trial sponsors seek from their insurance brokers.
The approval process for new drugs and medical devices is expensive and complicated. It is estimated that it takes an average of 10 years and over $1 billion to successfully bring a new drug to market.
We understand that any delays during the clinical trials process can have a material effect on a company’s ability to deliver a new drug.
Our global network of professionals with life science experience, make sure our clients successfully navigate this challenge and ease the administrative burden they may face in managing the insurance process for clinical trials.
Understanding and complying with insurance requirements to conduct clinical trials across the globe can be burdensome, complicated and time consuming.
Most countries have developed their own rules and regulations regarding insurance and reporting requirements for human clinical trials.
These regulations vary widely, and it is critical to anticipate insurance requirements as part of the submission to any country’s ethics committee.